TITLE

Intestinal Behçet’s Disease: Epidemiology, Pathophysiology and Potential of Mesalazine

AUTHOR(S)
Kitauchi, S.; Nishi, S.; Nishioka, S.
PUB. DATE
June 2000
SOURCE
BioDrugs;2000, Vol. 13 Issue 6, p409
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Behçet’s disease (BD) is a systemic inflammatory disease of unknown origin that affects various parts of the body. In some patients, the prognosis of the disease appears to be altered by the involvement of the intestine (intestinal BD). In intestinal BD, deep ulcers develop in the gastrointestinal tract, typically in the ileocaecum. Intestinal lesions in patients with BD are much more common in countries in the Far East, especially Japan. The tissue damage occurring in patients with BD is believed to be caused by oxygen radicals, which are promoted by proinflammatory cytokines and arachidonic acid metabolites. New formulations of mesalazine (5-aminosalicylic acid; 5-ASA) are now available for the treatment of intestinal BD. Mesalazine breaks the chain reaction of free radical production. Mesalazine may provide an effective treatment for the promotion of long term healing of mucosal ulceration of the intestine in patients with BD.
ACCESSION #
9522687

 

Related Articles

  • Endoscopic therapy with absolute ethanol for postoperative recurrent ulcers in intestinal Behcet's disease, and simple ulcers. Matsukawa, Masaaki; Yamasaki, Takeshi; Kouda, Takahiko; Kurihara, Minoru // Journal of Gastroenterology;2001, Vol. 36 Issue 4, p255 

    Background. When examined macroscopically and histologically, there are no differences between "simple" intestinal ulcers and intestinal ulcers of Behcet's disease. The postoperative recurrence of intestinal Behcet's disease and simple ulcers was frequently. Medical treatment for postoperative...

  • Multiple Perforations along the Entire Colon as a Complication of Intestinal Behcet's Disease: A Rare Case. Sekmen, Umit; Muftuoglu, Tolga; Sagiroglu, Julide; Gungor, Ozgun // Saudi Journal of Gastroenterology;Apr-Jun2008, Vol. 14 Issue 2, p85 

    Colonic complications of Behcet's disease due to intestinal involvement are rarely reported in the literature. Ulcers are the most frequently seen intestinal complications that cause bleeding and perforation predominantly in the ileocecal region. In this article, we report a patient with...

  • Chronological changes in the systemic manifestations of intestinal Behcet's disease and their significance in diagnosis. Sung Jae Shin; Sang Kil Lee; Tae Il Kim; Jae Hee Cheon; Eun Soo Kim; Byung Chang Kim; Sooyoung Park; Won Ho Kim // International Journal of Colorectal Disease;Nov2010, Vol. 25 Issue 11, p1371 

    Purpose: Intestinal Behçet's disease (BD) is challenging to diagnose, especially if the patient presents with typical colonoscopic findings of intestinal BD without systemic manifestations of BD. We performed this study to evaluate the systemic manifestations of BD in patients with typical...

  • SUPPORT FOR MYSTERY ILLNESS. Davis, Carol // Nursing Standard;8/16/2006, Vol. 20 Issue 49, p24 

    Behçet's disease is a rare autoimmune condition that can be difficult to diagnose and treat. Specialist nurse Gill Grundy is there to help.

  • Interferon-α treatment for acute myelitis and intestinal involvement in severe Behçet’s disease. Monastirli, A.; Chroni, E.; Georgiou, S.; Ellul, J.; Pasmatzi, E.; Papathanasopoulos, P.; Tsambaos, D. // QJM: An International Journal of Medicine;Oct2010, Vol. 103 Issue 10, p787 

    No abstract available.

  • Outcome Predictors for Intestinal Behçet's Disease. Jae Jun Park; Won Ho Kim; Jae Hee Cheon // Yonsei Medical Journal;Sep2013, Vol. 54 Issue 5, p1084 

    Behçet's disease (BD) is a multisystem inflammatory disorder that presents as recurrent oral and genital ulcers in conjunction with other dermatological and ocular manifestations. The prevalence of BD is higher in Middle and East Asia than in Western countries. Intestinal BD is a specific...

  • Intestinal Behçet's Disease: A True Inflammatory Bowel Disease or Merely an Intestinal Complication of Systemic Vasculitis? Duk Hwan Kim; Jae Hee Cheon // Yonsei Medical Journal;Jan2016, Vol. 57 Issue 1, p22 

    Behçet's disease (BD) is a multi-systemic inflammatory disorder of an unknown etiology and shows a chronic recurrent clinical course. When the disease involves the alimentary tract, it is called intestinal BD because of its clinical importance. Intestinal BD is more frequently reported in...

  • Juvenile Adamantiades-Behçet Disease. Vaiopoulos, aristeidis G.; Kanakis, Meletios a.; Kapsimali, Violetta; Vaiopoulos, Georgios; Kaklamanis, Phedon G.; Zouboulis, Christos C. // Dermatology (10188665);Apr2016, Vol. 232 Issue 2, p129 

    Adamantiades-Behçet disease (ABD) is a chronic, multisystemic, recurrent, inflammatory vascular disorder of unknown etiology. Patients with symptoms initially appearing at the age of 16 or less are considered as cases of juvenile-onset ABD (JABD). JABD is relatively rare compared to ABD of...

  • Evaluation of current therapeutic strategies in Behçet's disease. Alexoudi, Iliana; Kapsimali, Violetta; Vaiopoulos, Aristides; Kanakis, Meletios; Vaiopoulos, George // Clinical Rheumatology;Feb2011, Vol. 30 Issue 2, p157 

    Behçet's disease (BD) is a chronic relapsing vasculitis with multifunctional pathogenesis. The mucocutaneous and ocular lesions are the commonest manifestations, but BD also affects the musculoskeletal, intestinal, cardiac, and central nervous system. BD therapy is based on the suppression of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics